Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccine in Cancer Survivors
NCT01492582Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2012
- Primary completion
- Feb 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of qHPV vaccine, recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by University of Alabama at Birmingham. Started Jul 2012; status: completed.
02
Drugs
qHPV vaccinerecombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01492582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01492582.